Regulating in the Connected Health World, PharmaVoice contributor

Pharmaceutical regulation is both a hindrance and a necessity.  In September 2013, the FDA issued a final guidance for mobile medical apps.  This guidance provides clarity regarding which mobile apps are the focus of FDA oversight and which are not.  Together with January 2014’s draft social guidance we can begin to pain a picture in the FDA’s role in oversight, safety, and privacy. Read more: http://www.pharmavoice.com/archives/article.esiml?id=2886  

Connected Health Tools Improve Patient Outcomes (contributor), PharmaVoice

The ability for real-time information exchange enables better relationships, monitoring, and behavior change.  The Center for Connected Health has been studying the effects of connected health on patient behavior, engagement, and outcomes concluding that patients who used wireless devices were more likely to be engaged in their healthcare and have better outcomes. Read more: http://www.pharmavoice.com/archives/article.esiml?id=2884